Overview

Clopidogrel And Ticagrelor in Healthy Subjects

Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
To evaluate the pharmacodynamics of a lower Ticagrelor dose in healthy Korean volunteers compared with standard Clopidogrel agent.
Phase:
Phase 3
Details
Lead Sponsor:
Dong-A University
Treatments:
Adenosine
Clopidogrel
Polystyrene sulfonic acid
Ticagrelor
Ticlopidine